Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces SureSelect Focused Exome Kit
Saturday, October 25, 2014
Solution ideal for both high-throughput and benchtop next-generation sequencing applications.

Horizon Discovery Group Launches Xenograft Models of Breast Cancer
Thursday, October 23, 2014
Largest available collection of PDX cell lines, faithfully modelling human breast cancers.

BioDiscovery Launches NxClinical™ Software
Wednesday, October 22, 2014
A unique solution for complete case review and reporting for genetics labs.

Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems
Saturday, October 18, 2014
Enhancements offer improved performance for high throughput sequencing.

OGT Launches Medical Research Exome Array at ASHG
Wednesday, October 15, 2014
Hand-curated array provides complete coverage of over 4600 medically relevant genes.

Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.

DNASTAR Releases Lasergene 12.1 Software
Saturday, October 11, 2014
Lasergene 12.1 integrates cloud capability with ground computers.

Bio-Rad Introduces Real-Time PCR Assays for Rat Genome
Thursday, October 09, 2014
Wet-lab validated PrimePCR™ Rat Genome Assays ensure accurate quantitative PCR results.

3D Triculture Model for Evaluating Breast Cancer Progression
Wednesday, October 01, 2014
New application note introduces a more predictive and realistic model for drug screening of cancer therapeutics.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2530
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv